<div id="readability-page-1"><p>In a report released on December 5,  from HSBC maintained a Buy rating on Giant Biogene Holding Co. Ltd., with a price target of <span id="expert-recommendation-target">HK$46.40</span>. The company’s shares closed yesterday at HK$38.30.</p><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium  for data-backed insights and research tools you need to invest with confidence.  </li><li>  Subscribe to TipRanks' Smart Investor Picks  and see our data in action through our high-performing model portfolio - <u> now also 60% off </u></li></ul>  <p>The word on The Street in general, suggests a Strong Buy analyst consensus rating for Giant Biogene Holding Co. Ltd. with a HK$61.95 average price target, implying a 61.75% upside from current levels. In a report released on December 3, Citi also maintained a Buy rating on the stock with a HK$44.60 price target.</p></div>

02367

<p>HSBC maintains a Buy rating for Giant Biogene Holding Co. Ltd. with a price target of HK$46.40, while Citi also keeps a Buy rating with a target of HK$44.60. The stock closed at HK$38.30, and analysts suggest a Strong Buy consensus with an average target of HK$61.95, indicating a 61.75% upside potential.</p>

HSBC Sticks to Their Buy Rating for Giant Biogene Holding Co. Ltd. (2367)